Recent studies have described a number of genes that are frequently altered in medulloblastoma tumors and that have putative key roles in the development of the disease. We hypothesized that common germline genetic variations in these genes may be associated with medulloblastoma development. Based on recent publications, we selected 10 genes that were frequently altered in medulloblastoma: CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 (now renamed as KMT2D). Common genetic variants (single nucleotide polymorphisms) annotating these genes (n = 221) were genotyped in germline DNA (neonatal dried blood spot samples) from 243 childhood medulloblastoma cases and 247 control subjects from Sweden and Denmark. Eight genetic variants annotating three genes in the sonic hedgehog signaling pathway; CCND2, PTCH1, and GLI2, were found to be associated with the risk of medulloblastoma (P(combined)
Notes
Cites: Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2413-921914837
Cites: J Clin Oncol. 2014 Dec 20;32(36):4155-6125403219
Cites: Nature. 2012 Aug 2;488(7409):43-822722829
Cites: Nature. 2012 Aug 2;488(7409):49-5622832581
Cites: Nature. 2012 Aug 2;488(7409):100-522832583
Cites: Nature. 2012 Aug 2;488(7409):106-1022820256
Cites: J Med Genet. 1993 Jun;30(6):460-48326488
Cites: Nat Genet. 2006 Aug;38(8):904-916862161
Cites: PLoS Genet. 2006 Dec;2(12):e19017194218
Cites: Am J Hum Genet. 2007 Sep;81(3):559-7517701901